EUVIMEDEUVIMED entdecken
Crossref

Younger Age Is Associated With Slower PSA Decline After Low‐Dose‐Rate Brachytherapy for Localized Prostate Cancer

Yasushi Nakai iD, Kenta Onishi iD, Makito Miyake iD, Kaori Yamaki iD, Fumiaki Isohashi iD, Isao Asakawa, Nobumichi Tanaka iD

International Journal of Urology · 2026

DOI: 10.1111/iju.70653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2026. Verfasst von Yasushi Nakai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, Nara, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Prostate-Specific Antigen, Neoplasm Recurrence, Local. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the association of age with PSA kinetics and biochemical control after low‐dose‐rate brachytherapy (LDR‐BT).

Methods

We retrospectively analyzed 347 patients treated with LDR‐BT alone without androgen deprivation therapy between 2004 and 2015. Longitudinal PSA changes were evaluated using linear mixed‐effects models with natural cubic splines for time. Age was modeled as a continuous fixed effect, including interactions with the spline terms for time. Time to PSA nadir < 0.2 ng/mL was evaluated using Cox proportional hazards models, whereas biochemical recurrence was evaluated using Fine–Gray competing‐risk regression with death treated as a competing event.

Results

Younger age was significantly associated with slower PSA decline over 5 years ( p < 0.001). Each 1‐year increase in age was associated with model‐estimated PSA levels relative to baseline that were 4.6%, 6.4%, and 4.3% lower at 1, 3, and 5 years, respectively. This association remained significant after adjustment for Gleason grade group and treatment era and after excluding patients with PSA bounce (both p < 0.001). Median time to PSA nadir < 0.2 ng/mL was 54 months in patients aged < 65 years and 36 months in those aged ≥ 75 years. Increasing age was associated with earlier achievement of PSA nadir < 0.2 ng/mL (HR 1.04 per year, 95% CI 1.02–1.06) but was not significantly associated with biochemical recurrence.

Conclusions

Age was significantly associated with PSA kinetics following LDR‐BT, with younger patients showing slower PSA decline and a delayed achievement of PSA nadir < 0.2 ng/mL. However, these age‐related differences were not associated with biochemical recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapyProstate-Specific AntigenNeoplasm Recurrence, LocalHumansMaleRetrospective StudiesAgedAge FactorsMiddle AgedAged, 80 and overNeoplasm GradingRadiotherapy DosageProstate

Stichwörter der Autor:innen

PSA kineticsagebrachytherapyprostate cancerprostate‐specific antigen

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, Nara Medical University, Nara, Japan.
  • Department of Prostate Brachytherapy, Nara Medical University, Nara, Japan.
  • Department of Radiation Oncology, Nara Medical University, Nara, Japan.
  • Department of Radiation Oncology, Nara City Hospital, Nara, Japan.

ORCID-Profile: Yasushi Nakai, Kenta Onishi, Makito Miyake, Kaori Yamaki, Fumiaki Isohashi, Nobumichi Tanaka

Zitieren

APA

Nakai, Y., Onishi, K., Miyake, M., Yamaki, K., Isohashi, F., Asakawa, I., & Tanaka, N. (2026). Younger Age Is Associated With Slower PSA Decline After Low‐Dose‐Rate Brachytherapy for Localized Prostate Cancer. International Journal of Urology. https://doi.org/10.1111/iju.70653

Vancouver

Nakai Y, Onishi K, Miyake M, Yamaki K, Isohashi F, Asakawa I, et al. Younger Age Is Associated With Slower PSA Decline After Low‐Dose‐Rate Brachytherapy for Localized Prostate Cancer. International Journal of Urology. 2026. doi:10.1111/iju.70653

BibTeX
@article{Nakai2026,
  author = {Nakai, Yasushi and Onishi, Kenta and Miyake, Makito and Yamaki, Kaori and Isohashi, Fumiaki and Asakawa, Isao and Tanaka, Nobumichi},
  title = {Younger Age Is Associated With Slower PSA Decline After Low‐Dose‐Rate Brachytherapy for Localized Prostate Cancer},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70653}
}
Kostenlos starten →